Back

Select your region

Corporate

Europe:

Flag Albania Albania Flag Bosnia and Herzegovina Bosnia and Herzegovina Flag Bulgaria Bulgaria Flag Croatia Croatia Flag Cyprus Cyprus Flag Montenegro Montenegro Flag Czech Republic Czech Republic Flag Denmark Denmark Flag Estonia Estonia Flag Spain Spain Flag Kosovo Kosovo Flag Lithuania Lithuania Flag Latvia Latvia Flag Luxembourg Luxembourg Flag Macedonia Macedonia Flag Germany Germany Flag Poland Poland Flag Portugal Portugal Flag Romania Romania Flag Serbia Serbia Flag Slovakia Slovakia Flag Slovenia Slovenia Flag Switzerland Switzerland Flag Sweden Sweden Flag Turkey Turkey Flag Hungary Hungary Flag United Kingdom United Kingdom Flag Italy Italy

Asia:

Flag UAE UAE Flag Hong Kong Hong Kong Flag Kuwait Kuwait Flag Lebanon Lebanon

Africa:

Flag South Africa South Africa

Arrange a consultation about stem cells

Learn more

Get in touch with us today!

Would you like to find out more about our services? Fill out the form below and we will contact you as soon as possible to provide you with all the necessary information and answer your questions.

    We would like to point out that the personal data provided in the form will be processed by FamiCord Suisse, based in Switzerland (BusinessPark Zug Sumpfstrasse 26, 6302 Zug), for the purpose of contacting you by telephone in connection with the provision of service information.

    Image

    List of
    transplantations

    List of uses for stem cells approved by the FamiCord Group’s laboratories:

    Image
    List of uses for stem cells approved by the FamiCord Group’s laboratories:
    Nr. Source Source type Diagnosis Medical sector Year of application Therapy Country Age of the recipient
    601 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2026 Standard Therapy USA 32
    602 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Argentina 34
    603 Apheresis Allogeneic Other Malignancy, Specify Hematology 2026 Standard Therapy USA 68
    604 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Switzerland 63
    605 Apheresis Allogeneic T-Cell Non-Hodgkin lymphoma Hematology 2026 Standard Therapy Argentina 70
    606 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2026 Standard Therapy Czechia 52
    607 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2026 Standard Therapy France 62
    608 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Italy 20
    609 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Germany 53
    610 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy United Kingdom 56
    611 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2026 Standard Therapy Germany 71
    612 Apheresis Allogeneic Chronic Myelomonocytic Leukemia Hematology 2026 Standard Therapy USA 54
    613 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2026 Standard Therapy Hungary 36
    614 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy France 47
    615 Cord Tissue Allogeneic – Related Chronic renal disease Endocrinology 2025 Experimental Therapy Romania 50
    616 Cord Tissue Allogeneic – Related Autism Neurology 2025 Experimental Therapy Romania 6
    617 Cord Tissue Autologous Autism Neurology 2025 Experimental Therapy Romania 6
    618 Cord Tissue Allogeneic – Unrelated Degenerative and traumatic cartilage damage Orthopedics 2025 Experimental Therapy Poland 57,2
    619 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2025 Experimental Therapy Poland 3,1
    620 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2025 Experimental Therapy Poland 3,4
    621 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2025 Experimental Therapy Poland 2,8
    622 Cord Tissue Allogeneic – Unrelated Autism Neurology 2025 Experimental Therapy Poland 5,9
    623 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2025 Experimental Therapy Poland 11,9
    624 Cord Tissue Allogeneic – Unrelated Degenerative and traumatic cartilage damage Orthopedics 2025 Experimental Therapy Poland 54,2
    625 Cord Tissue Allogeneic – Unrelated Degenerative and traumatic cartilage damage Orthopedics 2025 Experimental Therapy Poland 78,4
    626 Cord Tissue Allogeneic – Unrelated Autism Neurology 2025 Experimental Therapy Poland 6,8
    627 Cord Tissue Allogeneic – Unrelated Degenerative and traumatic cartilage damage Orthopedics 2025 Experimental Therapy Poland 58,2
    628 Cord Tissue Autologous Autism Neurology 2025 Experimental Therapy Romania 5
    629 Cord Tissue Allogeneic – Related Autism Neurology 2025 Experimental Therapy Romania 5
    630 Cord Tissue Allogeneic – Unrelated Autism Neurology 2025 Experimental Therapy Poland 4,1
    631 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2025 Experimental Therapy Poland 7,9
    632 Cord Tissue Allogeneic – Unrelated Autism Neurology 2025 Experimental Therapy Poland 7,8
    633 Cord Tissue Allogeneic – Unrelated Degenerative and traumatic cartilage damage Orthopedics 2025 Experimental Therapy Poland 25,8
    634 Cord Tissue Allogeneic – Unrelated Autism Neurology 2025 Experimental Therapy Poland 6,8
    635 Cord Tissue Allogeneic – Unrelated Progressive bulbar palsy Neurology 2025 Experimental Therapy Poland 62,3
    636 Cord Tissue Allogeneic – Unrelated Encephalopathy Neurology 2025 Experimental Therapy Poland 67,2
    637 Cord Tissue Allogeneic – Unrelated Autism Neurology 2025 Experimental Therapy Poland 7,8
    638 Cord Tissue Allogeneic – Unrelated Degenerative and traumatic cartilage damage Orthopedics 2025 Experimental Therapy Poland 61,9
    639 Cord Tissue Allogeneic – Unrelated Autism Neurology 2025 Experimental Therapy Poland 5,11
    640 Cord Tissue Allogeneic – Unrelated Autism Neurology 2025 Experimental Therapy Poland 6,8
    641 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2025 Experimental Therapy Poland 1,5
    642 Cord Tissue Allogeneic – Unrelated Myelitis Neurology 2025 Experimental Therapy Poland 38,8
    643 Cord Tissue Allogeneic – Unrelated Anemia Neurology 2025 Experimental Therapy Poland 3,2
    644 Cord Tissue Allogeneic – Unrelated Autism Neurology 2025 Experimental Therapy Poland 6,8
    645 Cord Tissue Allogeneic – Unrelated Autism Neurology 2025 Experimental Therapy Poland 7,1
    646 Cord Tissue Allogeneic – Unrelated Spinocerebellar Ataxia Neurology 2025 Experimental Therapy Poland 5,1
    647 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2025 Experimental Therapy Poland 1,2
    648 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2025 Experimental Therapy Poland 1,1
    649 Cord Tissue Allogeneic – Unrelated Autism Neurology 2025 Experimental Therapy Poland 5,11
    650 Cord Tissue Allogeneic – Unrelated Progressive bulbar palsy Neurology 2025 Experimental Therapy Poland 63
    651 Cord Tissue Allogeneic – Unrelated Autism Neurology 2025 Experimental Therapy Poland 15,2
    652 Cord Tissue Allogeneic – Unrelated GvHD Immunology 2025 Experimental Therapy Poland 13
    653 Cord Tissue Allogeneic – Unrelated Cartilage Lesions Orthopedics 2025 Experimental Therapy Poland 48,2
    654 Cord Tissue Allogeneic – Unrelated Cartilage Lesions Orthopedics 2025 Experimental Therapy Poland 51,6
    655 Cord Tissue Allogeneic – Unrelated GvHD Hematology 2025 Experimental Therapy Poland 12,9
    656 Cord Tissue Allogeneic – Unrelated Autism Neurology 2025 Experimental Therapy Poland 10,1
    657 Cord Tissue Allogeneic – Unrelated Autism Neurology 2025 Experimental Therapy Poland 8,4
    658 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2025 Experimental Therapy Poland 3,7
    659 Cord Tissue Allogeneic – Unrelated Cerebral Infarction Neurology 2025 Experimental Therapy Poland 57,8
    660 Cord Tissue Allogeneic – Unrelated Autism Neurology 2025 Experimental Therapy Poland 7,7
    661 Cord Tissue Allogeneic – Unrelated Cerebellar Syndrome Neurology 2025 Experimental Therapy Poland 43,4
    662 Cord Tissue Allogeneic – Unrelated Cartilage Lesions Orthopedics 2025 Experimental Therapy Poland 61,1
    663 Cord Tissue Allogeneic – Unrelated Cartilage Lesions Orthopedics 2025 Experimental Therapy Poland 57,9
    664 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2025 Experimental Therapy Poland 1,2
    665 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2025 Experimental Therapy Poland 7,1
    666 Cord Tissue Allogeneic – Unrelated Autism Neurology 2025 Experimental Therapy Poland 3
    667 Cord Blood Allogeneic – Related Thalassemia Major Hematology 2025 Standard Therapy Turkey 5,9
    668 Cord Blood Autologous Aplastic Anemia Hematology 2025 Standard Therapy Poland 2
    669 Cord Blood Allogeneic – Related Thalassemia Major Hematology 2025 Standard Therapy Turkey 6,8
    670 Cord Blood Allogeneic – Related Cerebral Palsy Neurology 2025 Experimental Therapy Portugal 1 year and 8 months
    671 Cord Blood Autologous Autism Neurology 2025 Experimental Therapy Romania 5
    672 Cord Blood Allogeneic Acute lymphoblastic leukemia Hematology 2025 Standard Therapy Poland 13
    673 Cord Blood Autologous Autism Neurology 2025 Experimental Therapy Poland 5 ,5
    674 Cord Blood Autologous Autism Neurology 2025 Experimental Therapy Poland 7,2
    675 Cord Blood Allogeneic Thalassemia Major Hematology 2025 Standard Therapy Turkey 10,9
    676 Cord Blood Autologous Autism Neurology 2025 Experimental Therapy Poland 4,1
    677 Cord Blood Autologous Cerebral Palsy Neurology 2025 Experimental Therapy Poland 3,1
    678 Cord Blood Autologous Autism Neurology 2025 Experimental Therapy Poland 5,2
    679 Cord Blood Autologous Autism Neurology 2025 Experimental Therapy Poland 2,11
    680 Cord Blood Autologous Unbalanced AVSD Cardiovascular 2025 Experimental Therapy Poland 5 months
    681 Cord Blood Allogeneic – Related Relapsed Lymphoblastic Leukemia Hematology 2025 Standard Therapy Turkey 8,5
    682 Cord Blood Autologous Autism Neurology 2025 Experimental Therapy Poland 10,1
    683 Cord Blood Autologous Autism Neurology 2025 Experimental Therapy Poland 5,7
    684 Cord Blood Autologous Autism Neurology 2025 Experimental Therapy Poland 4,4
    685 Cord Blood Autologous Autism Neurology 2025 Experimental Therapy Poland 5,5
    686 Cord Blood Autologous Autism Neurology 2025 Experimental Therapy Poland 5,4
    687 Cord Blood Autologous Autism Neurology 2025 Experimental Therapy Poland 3,9
    688 Cord Blood Allogeneic – Related D57.1 Sickle Cell Anemia Hematology 2025 Standard Therapy Turkey 5 years 6 months
    689 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy France 66
    690 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 63
    691 Bone Marrow Family Allogeneic Myelofibrosis Hematology 2025 Standard Therapy Poland 71
    692 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy United Kingdom 72
    693 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy France 47
    694 Bone Marrow Family Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Ukraine 43
    695 Bone Marrow Family Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Italy 49
    696 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy France 51
    697 Bone Marrow Family Allogeneic Philadelphia – positive Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Germany 61
    698 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy France 58
    699 Bone Marrow Family Allogeneic Myelofibrosis Hematology 2025 Standard Therapy NETHERLANDS 63
    700 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 65